Chemoinformaics analysis of Phenazine methosulfate
| Molecular Weight | 306.343 | nRot | 1 |
| Heavy Atom Molecular Weight | 292.231 | nRig | 16 |
| Exact Molecular Weight | 306.067 | nRing | 3 |
| Solubility: LogS | -2.28 | nHRing | 1 |
| Solubility: LogP | 2.365 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 16 |
| nHA | 5 | APOL | 41.0231 |
| nHD | 0 | BPOL | 26.1549 |
| QED | 0.397 |
| Synth | 2.214 |
| Natural Product Likeliness | -0.121 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.999 |
| HIA | 0.015 |
| CACO-2 | -4.942 |
| MDCK | 0.0000302 |
| BBB | 0.989 |
| PPB | 0.902925 |
| VDSS | 0.606 |
| FU | 0.0441673 |
| CYP1A2-inh | 0.987 |
| CYP1A2-sub | 0.951 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.837 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.068 |
| CYP2d6-inh | 0.956 |
| CYP2d6-sub | 0.741 |
| CYP3a4-inh | 0.026 |
| CYP3a4-sub | 0.288 |
| CL | 4.661 |
| T12 | 0.71 |
| hERG | 0.015 |
| Ames | 0.912 |
| ROA | 0.212 |
| SkinSen | 0.076 |
| Carcinogencity | 0.896 |
| EI | 0.99 |
| Respiratory | 0.538 |
| NR-Aromatase | 0.236 |
| Antiviral | Yes |
| Prediction | 0.751493 |